Allergy and Immunology, Allergy · Rockledge, FL
NPI
1891957031
Since 2008
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3140 Suntree Blvd Ste 5
Rockledge, FL, 32955
Phone (321) 985-4200
Groups this clinician bills Medicare through
Medicare paid, 2024
$605K
25,966 services
Medicare patients, 2024
540
Average age 73
Drug cost, 2024
$1.1M
857 prescriptions
Company payments, 2025
$19K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pavana K Beerelli was code J2357 (injection, omalizumab, 5 mg), 7,892 times for 17 patients. In total Pavana K Beerelli billed 25,966 services in 27 codes, and Medicare paid $605K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 7,892 | 17 | $29.81 | $235K |
| 95004 Test - Miscellaneous | Office | 3,012 | 56 | $2.69 | $8,092 |
| 95165 Treatment - Miscellaneous | Office | 880 | 24 | $8.97 | $7,893 |
| 99214 Office E&M - Established | Office | 623 | 382 | $92.03 | $57K |
| 96372 Injection Administration | Office | 451 | 45 | $10.33 | $4,658 |
| 95117 Treatment - Miscellaneous | Office | 441 | 34 | $7.75 | $3,419 |
| 99204 Office E&M - New | Office | 269 | 269 | $120.06 | $32K |
| 95115 Treatment - Miscellaneous | Office | 192 | 17 | $6.08 | $1,167 |
| 95018 Test - Miscellaneous | Office | 126 | 14 | $15.02 | $1,893 |
| 94010 Pulmonary Function Testing | Office | 94 | 76 | $17.62 | $1,656 |
| 99213 Office E&M - Established | Office | 70 | 67 | $55.74 | $3,902 |
| 95076 Test - Miscellaneous | Office | 15 | 15 | $93.63 | $1,405 |
By year: 2022 $143K for 8,121 services; 2023 $251K for 12,279 services; 2024 $605K for 25,966 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pavana K Beerelli prescribed most often to Medicare patients was Ipratropium Bromide, with 99 prescriptions and refills. In total Pavana K Beerelli wrote 857 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 99 | 155 | 57 | $4,096 |
| Triamcinolone Acetonide Generic | 87 | 100 | 67 | $1,059 |
| Fluticasone Propionate Generic | 86 | 203 | 52 | $1,671 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 61 | 81 | 17 | $50K |
| Xolair Omalizumab | 53 | 53 | Under 11 | $148K |
| Mupirocin Generic | 52 | 52 | 31 | $321 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 47 | 56 | 29 | $1,229 |
| Epinephrine Generic | 42 | 43 | 39 | $8,705 |
| Montelukast Sodium Generic | 42 | 128 | 18 | $334 |
| Cutaquig Immun Glob G(Igg)-Hipp/Maltose | 26 | 26 | Under 11 | $105K |
| Tezspire Tezepelumab-Ekko | 25 | 29 | Under 11 | $115K |
| Cuvitru Immun Glob G(Igg)/Gly/Iga Ov50 | 24 | 24 | Under 11 | $286K |
| Omeprazole Generic | 19 | 38 | 15 | $218 |
| Levocetirizine Dihydrochloride Generic | 16 | 47 | Under 11 | $283 |
| Azelastine Hcl Generic | 16 | 34 | Under 11 | $384 |
Brand drugs: 350 claims; generic drugs: 507 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pavana K Beerelli $19K ($19K in general payments such as food, travel and fees) from 22 companies. The largest payer was Optinose US, Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 14 | $12K |
| AstraZeneca Pharmaceuticals LP AZN | 19 | $5,378 |
| Regeneron Healthcare Solutions, Inc. REGN | 22 | $582 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $274 |
| Genzyme Corporation SNY | 6 | $156 |
| Pfizer Inc. PFE | 10 | $154 |
| Grifols USA, LLC | 5 | $115 |
| BioCryst US Sales Co., LLC | 4 | $96.21 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $94.36 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 3 | $67.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.